Thomas Charles Wood1, Nicholas Raison2, Oussama El-Hage3, Kamran Ahmed3, Declan Cahill4, Benjamin J Challacombe5, Muhammad Shamim Khan6, Prokar Dasgupta3. 1. Brighton and Sussex Medical School, Audrey Emerton Building, Eastern Road, Brighton, BN2 5BE, UK. 2. MRC Centre for Transplantation, King's College London, Guy's Hospital, London, SE1 9RT, UK. nicholas.raison@kcl.ac.uk. 3. MRC Centre for Transplantation, King's College London, Guy's Hospital, London, SE1 9RT, UK. 4. Royal Marsden Hospital, London, SW3 6JJ, UK. 5. Department of Urology, Guy's and St. Thomas' Hospital NHS Foundation Trust, London, SE1 9RT, UK. 6. Guy's Hospital and King's College, London School of Medicine, London, UK.
Abstract
BACKGROUND: Ureteropelvic junction obstruction (UPJO) is characterised by an obstruction compromising the passage of urine from the renal pelvis into the ureter, and can be corrected by Robot-Assisted Laparoscopic Pyeloplasty (RALP). We aimed to evaluate the surgical outcomes of RALP, and examine the rates of true pain resolution following the procedure. METHODS: We retrospectively explored the records of all patients who underwent RALP between April 2005 and January 2017. Measures of success were defined as the prevention of deterioration in split renal function and resolution of obstruction, and the resolution or improvement in subjective pain levels. RESULTS: 83 patients were included in this series. Mean patient age was 40.8 years. 38 patients had a left sided RALP, whilst 45 underwent RALP on the right. Crossing vessels were identified in 53.0% of patients. Mean operative time was 148.0 min. 68 patients had pain as their presenting feature. Following RALP, the pain resolved in 69.2% (n = 47), improved in 26.5% (n = 18), and remained the same in 4.4% (n = 3). 11.8% (n = 8) of patients required referral to other specialities for pain management. Success from a radiological perspective of cleared obstruction and arrest of deteriorating renal function was 97.6%. CONCLUSIONS: Our individual outcomes demonstrate a high success rate regarding resolution of obstruction and preventing deterioration in renal function. We also report that a number of patients, who despite meeting the radiological criteria to undergo RALP, had alternate underlying causes for their pain symptoms. For this reason, we propose that the primary measure of success for RALP should be based on renal function and radiological outcomes, rather than the outcomes relating to pain. Both surgeons and patients should be aware that whilst RALP is a highly successful procedure, persistence of pain may be due to overlapping clinical conditions which can be managed by a multidisciplinary approach.
BACKGROUND:Ureteropelvic junction obstruction (UPJO) is characterised by an obstruction compromising the passage of urine from the renal pelvis into the ureter, and can be corrected by Robot-Assisted Laparoscopic Pyeloplasty (RALP). We aimed to evaluate the surgical outcomes of RALP, and examine the rates of true pain resolution following the procedure. METHODS: We retrospectively explored the records of all patients who underwent RALP between April 2005 and January 2017. Measures of success were defined as the prevention of deterioration in split renal function and resolution of obstruction, and the resolution or improvement in subjective pain levels. RESULTS: 83 patients were included in this series. Mean patient age was 40.8 years. 38 patients had a left sided RALP, whilst 45 underwent RALP on the right. Crossing vessels were identified in 53.0% of patients. Mean operative time was 148.0 min. 68 patients had pain as their presenting feature. Following RALP, the pain resolved in 69.2% (n = 47), improved in 26.5% (n = 18), and remained the same in 4.4% (n = 3). 11.8% (n = 8) of patients required referral to other specialities for pain management. Success from a radiological perspective of cleared obstruction and arrest of deteriorating renal function was 97.6%. CONCLUSIONS: Our individual outcomes demonstrate a high success rate regarding resolution of obstruction and preventing deterioration in renal function. We also report that a number of patients, who despite meeting the radiological criteria to undergo RALP, had alternate underlying causes for their pain symptoms. For this reason, we propose that the primary measure of success for RALP should be based on renal function and radiological outcomes, rather than the outcomes relating to pain. Both surgeons and patients should be aware that whilst RALP is a highly successful procedure, persistence of pain may be due to overlapping clinical conditions which can be managed by a multidisciplinary approach.
Authors: Matthew R Thom; Mohammed Haseebuddin; Timur M Roytman; Brian M Benway; Sam B Bhayani; Robert S Figenshau Journal: Int Braz J Urol Date: 2012 Jan-Feb Impact factor: 1.541
Authors: Ananthakrishnan Sivaraman; Raymond J Leveillee; Manoj B Patel; Sanket Chauhan; Jorge E Bracho; Charles R Moore; Rafael F Coelho; Kenneth J Palmer; Oscar Schatloff; Vincent G Bird; Ravi Munver; Vipul R Patel Journal: Urology Date: 2011-12-14 Impact factor: 2.649
Authors: Patrick W Mufarrij; Michael Woods; Ojas D Shah; Michael A Palese; Aaron D Berger; Raju Thomas; Michael D Stifelman Journal: J Urol Date: 2008-08-15 Impact factor: 7.450
Authors: Jonathan E Bernie; Ramakrishna Venkatesh; James Brown; Thomas A Gardner; Chandru P Sundaram Journal: JSLS Date: 2005 Jul-Sep Impact factor: 2.172